SMEAL WIKI
Home
Network graph
Departments
Topics
Papers
Cancer research
OpenAlex concept - C502942594
Field
Subfield
Domain
OpenAlex
C502942594
Smeal faculty
Jing Pan
- score 5.1
Min Ding
- score 1.7
Charles Hugh Smith
- score 1.2
Zhenzhen Yan
- score 0.7
Carolyn T. Dang
- score 0.6
Ron Johnson
- score 0.4
Papers
Comprehensive molecular characterization of urothelial bladder carcinoma
(2014)
- cites 3040
Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines [see comments]
(1996)
- cites 286
Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis
(2019)
- cites 241
Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing
(2012)
- cites 207
LncRNA DGCR5 promotes lung adenocarcinoma (LUAD) progression via inhibiting hsa‐mir‐22‐3p
(2017)
- cites 187
miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1
(2016)
- cites 186
The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistance
(2021)
- cites 145
LncRNA DGCR5 contributes to CSC‐like properties via modulating miR‐330‐5p/CD44 in NSCLC
(2018)
- cites 81
Targeting Glutamine Metabolism to Enhance Immunoprevention of EGFR‐Driven Lung Cancer
(2022)
- cites 70
Honokiol targets mitochondria to halt cancer progression and metastasis
(2016)
- cites 68
Knockdown of long non-coding RNA H19 inhibits multiple myeloma cell growth via NF-κB pathway
(2017)
- cites 66
COX6B2 drives metabolic reprogramming toward oxidative phosphorylation to promote metastasis in pancreatic ductal cancer cells
(2020)
- cites 60
Identification of a Subtype of Hepatocellular Carcinoma with Poor Prognosis Based on Expression of Genes within the Glucose Metabolic Pathway
(2019)
- cites 36
Subpathway Analysis of Transcriptome Profiles Reveals New Molecular Mechanisms of Acquired Chemotherapy Resistance in Breast Cancer
(2022)
- cites 24
STAT1‐induced upregulation of lncRNA RHPN1‐AS1 predicts a poor prognosis of hepatocellular carcinoma and contributes to tumor progression via the miR‐485/CDCA5 axis
(2020)
- cites 23
Abstract 2463: Protein folding chaperonin as biological indicator for cancer progression and metastasis
(2023)
- cites 0